Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: Relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings

Journal of Neuroimmunology

Volumn 142, Issue 1-2, 2003, Pages 149-158

  Fainardi, Enrico ^a,b   Rizzo, Roberta ^a   Melchiorri, Loredana ^a   Vaghi, Luca ^a   Castellazzi, Massimiliano ^a   Marzola, Andrea ^a   Govoni, Vittorio ^a   Paolino, Ezio ^a   Tola, Maria Rosaria ^a   Granieri, Enrico ^a   Baricordi, Olavio Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Cerebrospinal fluid; IL 10; Multiple sclerosis; SHLA G; SHLA I

Indexed keywords

HLA ANTIGEN CLASS 1; HLA G ANTIGEN; INTERLEUKIN 10; DIAGNOSTIC AGENT; GADOLINIUM; HLA ANTIGEN; HLA-G ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMAGE ENHANCEMENT; IMMUNOREGULATION; INTERMETHOD COMPARISON; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; IMMUNOLOGY; INFLAMMATION; METHODOLOGY; MIDDLE AGED; NEUROLOGIC DISEASE; SOLUBILITY; STATISTICS; VALIDATION STUDY; WESTERN BLOTTING;

ADULT; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GADOLINIUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INFLAMMATION; INTERLEUKIN-10; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; SOLUBILITY;

EID: 12144290319     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00266-2     Document Type: Article

References (61)

1. Alvarez-Cermeño J.C., Villar L.M., Nocito M., Bootello A., Gonzales-Porque P. Intrathecal synthesis of soluble HLA class I antigens in multiple sclerosis. J. Neuroimmunol. 36:1992;77-79.
2. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am. J. Pathol. 159:2001;71-77.
3. Bainbridge D.R., Ellis S.A., Sargent I.L. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol. 48:2000;17-26.
4. Bainbridge D., Ellis S., Le Bouteiller P., Sargen I. HLA-G remains a mystery. Trends Immunol. 22:2001;548-552.
5. Carosella E.D., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol. 22:2001;553-555.
6. Carrieri P.B., Provitera V., De Rosa T., Tartaglia G., Gorga F., Perrella O. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20:1998;373-382.
7. + cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33:2003;125-134.
8. Correale J., Gilmore W., McMillan M., Li S., McCarthy K., Le T., Weiner L.P. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154:1995;2959-2968.
9. Crisa L., Mc Master M.T., Ishii J.K., Fisher S.J., Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J. Exp. Med. 186:1997;289-298.
10. Emmer P.I., Steegers E.A.P., van Lierop M.J., Steegers-Theunissen R.P.M., Loke Y.W., Joosten I. Amniotic fluid soluble human leukocyte antigen G is markedly decreased in offspring with neural tube defects. Early Hum. Dev. 66:2002;101-105.
11. Fainardi E., Granieri E., Tola M.R., Melchiorri L., Vaghi L., Rizzo R., Castellazzi M., Ceruti S., Paolino E., Baricordi O.R. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA-class I molecules. J. Neuroimmunol. 133:2002;151-159.
12. Filaci G., Contini P., Bronci S., Gazzola P., Lanza L., Scudeletti M., Indiveri F., Mancardi L., Puppo F. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum. Immunol. 54:1997;54-62.
13. + cells by interacting CD8. J. Immunol. 164:2000;6100-6104.
14. Fournel S., Huc X., Aguerre-Gir M., Solier C., Legros M., Praud-Brethenou C., Moussa M., Chaouat G., Berrebi A., Bensussan A., Lenfant F., Le Bouteiller P. Comparative reactivity of different HLA-G mAb to soluble HLA-G molecules. Tissue Antigens. 55:2000;510-518.
15. Fujii T., Ishitani A., Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153:1994;5516-5524.
16. Fuzzi B., Rizzo R., Criscuoli L., Noci I., Melchiorri L., Scarselli B., Bencini E., Menicucci E., Baricordi O.R. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur. J. Immunol. 32:2002;311-315.
17. Gallo P., Sivieri S., Rinaldi L., Yan X.-B., Lolli F., De Rossi A., Tavolato B. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J. Neurol. Sci. 126:1994;49-53.
18. Goldman-Wohl D.S., Ariel I., Greenfield C., Hanoch J., Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol. Hum. Reprod. 6:2000;88-95.
19. Hunt J., Jadhav L., Chu W., Geraghty D.E., Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. 183:2000;682-688.
20. Inostroza J., Munoz P., Espinoza R., Millaqueo L., Diaz P., Leiva L., Sorensen R. Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis. Hum. Immunol. 40:1994;179-184.
21. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., Schock S., Oertel W.H., Sommer N., Hemmer B. Oligoclonal expansion of memory CD8+ cells in cerebrospinal fluid from multiple sclerosis patients. Brain. 125:2002;538-550.
22. Kanai T., Fujii T., Unno N., Yamashita T., Hyodo H., Miki A., Hamai Y., Kozuma S., Taketani Y. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am. J. Reprod. Immunol. 45:2001;94-99.
23. Kanai T., Fujii T., Kozuma S., Yamashita T., Miki A., Kikuchi A., Taketani Y. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol. Hum. Reprod. 7:2001;195-200.
24. Kapasi K., Albert S.E., Yie S., Zavazava N., Librach C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 101:2000;191-200.
25. Kastrukoff L.F., Morgan N.G., Zecchini D., White R., Petkau A.J., Satoh J., Paty D.W. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J. Neuroimmunol. 86:1998;123-133.
26. Kermode A.G., Thompson A.J., Tofts P., MacManus D.G., Kendall B.E., Kingsley D.P.E., Moseley I.F., Rudge P., McDonald W.I. Breakdown of blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain. 113:1990;1477-1489.
27. Khosrotehrani K., Le Danff C., Reynaud-Mendel B., Dubertret L., Carosella E.D., Aractingi S. HLA-G expression in atopic dermatitis. J. Invest. Dermatol. 117:2001;750-752.
28. Kirszenbaum M., Moreau P., Gluckman E., Dausset J., Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4209-4213.
29. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology. 33:1983;1444-1452.
30. Le Bouteiller P., Solier C. Is antigen presentation the primary function of HLA-G? Microbes Infect. 3:2001;323-332.
31. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 105:2002;1949-1954.
32. Lublin D.F., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 46:1996;907-911.
33. Martino G., Hartung H.P. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 12:1999;309-321.
34. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., Poliani P.L., Grimaldi L.M.E. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 109:2000;3-9.
35. Mc Donald J.C., Adamashvili E. Soluble HLA: a review of literature. Hum. Immunol. 59:1998;387-403.
36. Miller D.H., Barkhof F., Nauta J.J.P. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain. 116:1993;1077-1094.
37. Moreau P., Cabestre F.A., Menier C., Gauiard U., Gourand L., Dausset J., Carosella E.D., Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 5:1999;803-811.
38. Ober C., Aldrich C., Rosinsky B., Roberton A., Walker M.A., Willadsen S., Verp M.S., Geraghty D.E., Hunt J.S. HLA-G1 protein expression is not essential for fetal survival. Placenta. 19:1998;127-132.
39. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J. Immunol. 16:2000;6426-6434.
40. Ott M., Seidl C., Westhoff U., Stecker K., Seifred E., Fischer P.A., Grosse-Wilde H. Soluble HLA class I and class II antigens in patients with multiple sclerosis. Tissue Antigens. 51:1998;301-304.
41. Paul P., Canestre F.A., Le Gal F.A., Khalin-Daher I., Le Danff C., Schimd M., Mercier S., Avril M.-F., Dausset J., Guillet G., Carosella E.D. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res. 59:1999;1954-1960.
42. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalin-Daher I., Vaseux G., Quiles R.M., Bermond F., Dausset J., Carosella E.D. Identification of HLA-G7 as a new splice variant of HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Hum. Immunol. 61:2000;1138-1149.
43. Pfeiffer K.A., Rebmann V., Passler M., van der Ven K., van der Ven H., Krebs D., Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum. Immunol. 61:2000;559-564.
44. Pfizenmaier K., Scheurich P., Schluter C., Kronke M. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J. Immunol. 138:1987;975-980.
45. Pober J.S., Gimbrone M.A. Jr., Lapierre L.A., Mendrick D.L., Fiers W., Rothlein R., Springer T.A. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1986;1893-1896.
46. Poser C.M., Paty D.W., Scheimberger L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for MS: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
47. Puppo F., Contini P., Ghio M., Brenci S., Scudelletti M., Filaci G., Ferrone S., Indiveri F. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8 (+) Fas (CD95) (+) T lymphocytes. Int. Immunol. 12:2000;195-203.
48. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 184:2001;101-122.
49. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Brooks A., Lüer W., Helwig A., Poser S. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
50. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Helwig A., Poser S. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:1995;82-88.
51. 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. U. S. A. 94:1997;5249-5254.
52. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
53. Silver N.C., Good C.D., Barker G.J., MacManus D.G., Thompson A.J., Moseley I.F., McDonald W.I., Miller D.H. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain. 120:1997;1149-1161.
54. Solier C., Aguerre-Girr M., Lenfant F., Campan A., Berrebi A., Rebmann V., Grosse-Wilde H., Le Bouteiller P. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur. J. Immunol. 32:2002;3576-3586.
55. van Boxel-Dezaire A.H.H., Hoff S.C.J., van Oosten B.W., Verweij C.L., Drager A.M., Ader H.J., van Houwelingen J.C., Barkhof F., Polman C.H., Nagelkerken L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45:1999;695-703.
56. Waubant E., Gee L., Bacchetti P., Sloan R., Cotleur A., Rudick R., Goodkin D. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J. Neuroimmunol. 112:2001;139-145.
57. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., Weiss E.H., Melms A., Weller M. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J. Immunol. 168:2002;4772-4780.
58. Wong G.H., Bartlett P.F., Clark-Lewis I., Battye F., Schrader J.W. Inducible expression of H-2 and Ia antigens on brain cells. Nature. 310:1984;688-691.
59. Yang Y., Chu W., Geraghty D.E., Hunt J.S. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J. Immunol. 156:1996;4224-4231.
60. Zavazava N., Kronke M. Soluble HLA class I antigens induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat. Med. 2:1996;1005-1010.
61. Zavazava N., Hausmann R., Muller-Rucholtz W. Inhibition of anti HLA-B7 alloreactive CTL by affinity purified soluble HLA. Transplantation. 51:1991;838-842.